Yüklüyor......
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
BACKGROUND/AIMS: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with Crohn’s disease (CD) are rare, particularly for Asian patients. We compared the key clinical outcomes (surgery, hospitalization, and corticosteroid use) of use of these two drugs in biolog...
Kaydedildi:
| Yayımlandı: | Gut Liver |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Editorial Office of Gut and Liver
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817934/ https://ncbi.nlm.nih.gov/pubmed/32839359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19377 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|